Ruedas-López Alba; Alonso-García Isaac; Lasarte-Monterrubio Cristina; Guijarro-Sánchez Paula; Gato Eva; Vázquez-Ucha Juan Carlos; Vallejo Juan Andrés; Fraile-Ribot Pablo Arturo; Fernández-Pérez Begoña; Velasco David; Gutiérrez-Urbón José María; Oviaño Marina; Beceiro Alejandro; González-Bello Concepción; Oliver Antonio; Arca-Suárez Jorge; Bou Germán
Abstract:
Infections caused by ceftolozane-tazobactam and ceftazidime-avibactam-resistant
P. aeruginosa
infections are an emerging concern. We aimed to analyze the underlying ceftolozane-tazobactam and ceftazidime-avibactam resistance mechanisms in all multidrug-resistant or extensively drug-resistant (MDR/XDR)
P. aeruginosa
isolates recovered during 1 year (2020) from patients with a documented
P. aeruginosa
infection.
Antimicrobial Agents and Chemotherapy:
2022
doi: 10.1128/AAC.02067-21
https://doi.org/doi: 10.1128/AAC.02067-21
Related